Search | Page 29 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  2. What is active treatment or active drug therapy?

    ... cure for a bone marrow failure disease is a bone marrow/ stem cell transplant . Unfortunately, a bone marrow transplant is not an ...

    FAQ last updated 03/15/2016 - 11:41pm.

  3. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy , such as azacitidine , ... patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  4. How do I decide between antithymocyte globulin (ATG) and bone marrow transplant for treatment of aplastic anemia?

    ... from attacking your bone marrow , letting your stem cells grow back and raising your blood count. This is a standard treatment for older patients or those without a stem cell donor. Stem cell transplantation involves putting blood-forming stem ...

    FAQ last updated 03/15/2016 - 11:50pm.

  5. RIC Transplant Using Haplo Donors

    ... -mismatched first-degree relatives utilizing PBSC as the stem cell source. The primary objective of the study is to estimate the incidence of ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  6. AML Therapy With Irradiated Allogeneic Cells

    ... must not be a candidate for an allo-hematopoietic stem cell transplant (HSCT) Patient must have a partially (>= 3/6 class I ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  7. Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

    ... of improvement (relapsed), previously treated with donor stem cell transplant . Biological therapies, such as cellular adoptive immunotherapy, ...

    Clinical Trial last updated 04/29/2016 - 10:34am.

  8. Hildegard Greinix, MD

    ... Government to the European Commission's directives on stem cells and tissues and she has been an active participant of the NIH ... electronic access to all scientific journals, the stem cell transplant community has become an international network allowing ...

    Bio last updated 03/11/2016 - 1:41pm.

  9. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    ... of differentiation (CD)-34+ allogeneic peripheral blood stem cell transplantation (PBSCT) on day 0. GVHD PROPHYLAXIS: Beginning on day ...

    Clinical Trial last updated 04/27/2016 - 1:56pm.

  10. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    ... sibling donor or are too old for hematopoietic stem cell transplant . Approximately two thirds of patients successfully respond ...

    Research Review last updated 05/02/2016 - 9:13am.